From Novartis, Bristol MS meds to new ADCs, here are 2020’s blockbuster drug launches

From Novartis, Bristol MS meds to new ADCs, here are 2020's blockbuster drug launches

Novo Nordisk nabs FDA nod for hemophilia A drug Esperoct but can’t launch until 2020

Novo Nordisk nabs FDA nod for hemophilia A drug Esperoct but can’t launch until 2020

10 Takeover Targets to Watch in 2019

0 Takeover Targets to Watch in 2019

The 2019 pipeline report: Changing the treatment paradigm

The 2019 pipeline report: Changing the treatment paradigm

7 drugs that raised eyebrows in Q3

7 drugs that raised eyebrows in Q3